Ministry of Commerce and Industry Directorate General of Foreign Trade
Knowledge PartnerIndia Trade Promotion Organisation (ITPO)
Home / Sectors / Pharmaceuticals

Pharmaceuticals

Medicaments, antibiotics, immunological products, dressings and bulk compounds from Thiruvananthapuram and Ernakulam.

US$ 36.6 mnKeralam’s exports, FY26
<1%Keralam’s share of India’s exports
3Scale-up openings across FTA markets
13New market and new product openings
Market access

How much of this sector enters duty-free

Share of the sector’s tariff lines in each FTA that are duty-free from day one, under a tariff rate quota, or excluded.

UAE98%
Australia100%
EFTA100%
UK100%
Oman100%
EU100%
New Zealand100%
Immediate duty-freeTariff rate quotaExcluded or special
Keralam products

Products that benefit, and where they are made

22 products exported from Keralam that benefit across the FTAs, with their main production and export clusters.

HS codeProductMain production and export clusters
300490MedicamentsThiruvananthapuram, Thrissur
300420Antibiotic medicamentsThiruvananthapuram, Ernakulam
300410Penicillin medicamentsThiruvananthapuram, Ernakulam
300450Vitamin medicamentsThiruvananthapuram, Thrissur
300390Other medicamentsThiruvananthapuram, Ernakulam
300590Medical dressingsThiruvananthapuram, Ernakulam
300215Immunological productsThiruvananthapuram
300214Immunological productsThiruvananthapuram
300431Insulin medicamentsThiruvananthapuram
300432Corticosteroid medsThiruvananthapuram, Ernakulam
300439Hormone medicamentsThiruvananthapuram, Ernakulam
294190AntibioticsThiruvananthapuram, Ernakulam
294200Organic compoundsThiruvananthapuram, Ernakulam
293339Heterocyclic compoundsThiruvananthapuram, Ernakulam
293359Pyrimidine compoundsThiruvananthapuram, Ernakulam
293499Nucleic acidsThiruvananthapuram, Ernakulam
293319Pyrazole compoundsThiruvananthapuram, Ernakulam
293329Imidazole compoundsThiruvananthapuram, Ernakulam
291815Citrate saltsThiruvananthapuram, Ernakulam
291811Lactic acidThiruvananthapuram, Ernakulam
130219Herbal extractsIdukki, Wayanad, Ernakulam
293629Other vitaminsThiruvananthapuram, Ernakulam
Opportunity matrix

Every product, every FTA market

Each cell shows the suggested category for a product in that market. Hover or tap a cell for the duty change and import demand.

IScale upIINew opportunityIIIFix supply sideIVNew productVDefocus
ProductHSUKEUUAEOmanAustraliaNew ZealandEFTA – NorwayEFTA – SwitzerlandEFTA – Iceland
Medicaments300490IIIIIIIIIIIIIIIIIIIIIIIIIII
Antibiotic medicaments300420IIIIIIIII·IIIIIIIIIIIIIII
Penicillin medicaments300410·III···V···
Vitamin medicaments300450IIIIIIIII··V···
Other medicaments300390IIIIII··IIIV···
Medical dressings300590····IV····
Immunological products300215IIIIIIIIIIIIIIIIIIIIIIIIII
Immunological products300214····IV····
Insulin medicaments300431IIIIIIIII·IIIIII···
Corticosteroid meds300432IIIIIIIII·IIIIIIIIIIIIIII
Hormone medicaments300439IIIIIIIII·IIIIIIIIIIIIIII
Antibiotics294190·III···V···
Organic compounds294200VVIV·V···
Heterocyclic compounds293339IIIVVIIIV···
Pyrimidine compounds293359IIIIVV·VIIIIIIIII
Nucleic acids293499IIIIVV·V···
Pyrazole compounds293319VIIVVIIIV···
Imidazole compounds293329IIIIVV·V···
Citrate salts291815·IV·······
Lactic acid291811·IV·······
Herbal extracts130219····IIII···
Other vitamins293629·····V···
Market by market

Import demand, duty change and action

Choose an FTA partner. Products are sorted by category, then by the size of import demand.

ProductHSImport demand (US$ mn)Duty, pre → post FTASuggested action
Heterocyclic compounds2933392976% → 0%Scale up
Pyrimidine compounds2933594626% → 0%New opportunity
Nucleic acids2934994596% → 0%New opportunity
Imidazole compounds2933291936% → 0%New opportunity
Medicaments30049013,5570%Fix supply side
Immunological products3002156,6670%Fix supply side
Hormone medicaments3004393,0910%Fix supply side
Corticosteroid meds3004326830%Fix supply side
Antibiotic medicaments3004203580%Fix supply side
Other medicaments3003901820%Fix supply side
Insulin medicaments3004311790%Fix supply side
Vitamin medicaments3004501120%Fix supply side
Pyrazole compounds29331914.126% → 0%Defocus
Organic compounds29420013.887% → 0%Defocus
Advantage against competitors

Where the FTA gives Keralam an edge

For key products in each market: India’s current share, the competitors India will now gain a tariff edge over, and the competitors that already had duty-free access.

EU average pre-FTA duty 6%

Pyrimidine compounds$14,787 MN market6% duty
India 2%Gain an edge over 75.2%At par with 21.9%
Lactic acid$316.3 MN market7% duty
India 0.2%Gain an edge over 68.5%At par with 27.4%
Citrate salts$394.1 MN market7% duty
India 1.3%Gain an edge over 51.7%At par with 30.8%
Nucleic acids$13,119 MN market6% duty
India 3.2%Gain an edge over 19.4%At par with 68.5%
Imidazole compounds$503.3 MN market6% duty
India 7.5%Gain an edge over 17%At par with 59.8%

UK average pre-FTA duty 5%

Nucleic acids$458.6 MN market6% duty
India 3.6%Gain an edge over 45%At par with 41.7%
Imidazole compounds$192.8 MN market6% duty
India 2.5%Gain an edge over 32.1%At par with 46.9%
Pyrimidine compounds$462.4 MN market6% duty
India 2.3%Gain an edge over 27.9%At par with 62.9%
Heterocyclic compounds$296.7 MN market6% duty
India 72.8%Gain an edge over 13.8%At par with 12.5%
Medicaments$13,557 MN market0% duty
India 6.9%Gain an edge over 0%At par with 88.5%

Australia average pre-FTA duty 3%

Immunological products$2,373 MN market3% duty
India 0%Gain an edge over 38.5%At par with 37.6%
Medical dressings$91.6 MN market3% duty
India 3.9%Gain an edge over 28.3%At par with 54.6%
Immunological products$93.9 MN market3% duty
India 0.1%Gain an edge over 21.1%At par with 57.2%
Herbal extracts$97.8 MN market2% duty
India 21%Gain an edge over 15.6%At par with 48.2%

UAE average pre-FTA duty 0%

Medicaments$3,304 MN market0% duty
India 7.3%Gain an edge over 0%At par with 89.8%
Antibiotic medicaments$150.1 MN market0% duty
India 12.2%Gain an edge over 0%At par with 86.5%
Immunological products$1,372 MN market0% duty
India 0.4%Gain an edge over 0%At par with 98.6%
Vitamin medicaments$76.4 MN market0% duty
India 5.9%Gain an edge over 0%At par with 93.1%
Hormone medicaments$788.9 MN market0% duty
India 1%Gain an edge over 0%At par with 98%

EFTA average pre-FTA duty 0%

Medicaments$44,779 MN market0% duty
India 0.1%Gain an edge over 0%At par with 98.9%
Immunological products$11,025 MN market0% duty
India 0%Gain an edge over 0%At par with 99%
Hormone medicaments$3,405 MN market0% duty
India 0%Gain an edge over 0%At par with 99%
Antibiotic medicaments$1,147 MN market0% duty
India 0.1%Gain an edge over 0%At par with 98.9%
Pyrimidine compounds$489.2 MN market0% duty
India 0.5%Gain an edge over 0%At par with 98.5%

New Zealand average pre-FTA duty 0%

Medicaments$766.4 MN market0% duty
India 9.9%Gain an edge over 0%At par with 87.4%
Antibiotic medicaments$28.2 MN market0% duty
India 11.2%Gain an edge over 0%At par with 87.8%
Herbal extracts$25.2 MN market0% duty
India 24.5%Gain an edge over 0%At par with 74.5%
Immunological products$193.7 MN market0% duty
India 0%Gain an edge over 0%At par with 99%
Hormone medicaments$69.6 MN market0% duty
India 0.7%Gain an edge over 0%At par with 98.3%

Oman average pre-FTA duty 3%

Medicaments$317.9 MN market0% duty
India 8.7%Gain an edge over 0%At par with 85.8%
Immunological products$129.9 MN market0% duty
India 0.4%Gain an edge over 0%At par with 98.6%
Heterocyclic compounds$6.65 MN market5% duty
India 88.7%Gain an edge over 0%At par with 3.7%
Organic compounds$2.86 MN market5% duty
India 55.8%Gain an edge over 0%At par with 0.2%
Nucleic acids$4.87 MN market5% duty
India 16.4%Gain an edge over 0%At par with 2.2%
India’s current share of the market’s importsCompetitors India will gain a tariff edge overCompetitors already duty-free, now at par with India

Values in US$ million, 2024. Source: ITC Trade Map.

State Government

Category-wise suggested interventions

Each partner cell shows that market’s total imports from the world in US$ million, with India’s share in brackets. The colour shows the suggested category.

IScale upIINew opportunityIIIFix supply sideIVNew productVDefocus

Pharmaceuticals

ProductIndia’s exports to world (US$ mn)UAEAustraliaEFTAUKOmanEUNew Zealand
General retail medicines17899.43304.44%4893.49%44779.20%13556.96%317.913%160617.72%766.49%
Miscellaneous organic chemicals1268.537.626%13.53.7%19.619.7%13.910%2.999%2197%1.33.4%
Retail non-penicillin antibiotics1208.8150.14%11314%1146.50%358.54%13.916.3%4670.62%28.211%
Pyridine-based chemicals1037.510.546%100.38%237.425.8%296.773%6.798%5255.47%1.625.6%
Retail penicillin medicines755.844.615.5%36.531.2%54.16%87.321.4%12.121%1356.16%10.18.7%
Non-penicillin bulk antibiotics640.49.415.3%31.924.8%161.50.5%8920%2.983.7%2652.94%2.10.8%
Complex heterocyclic/nucleic acids604.628.281%76.733.9%893.77.8%458.64%4.921%13119.23%24.40.3%
Plant-derived botanical extracts548.532.562%97.821%50.33.1%71.415.3%2.32%1203.57.8%25.217%
Botanical herbs and parts543.646.315%181.96%74.74.4%123.215.7%2.59%1429.413.8%14.55.5%
Pyrimidine-based chemicals523.44.540%17.611.1%489.22%462.42%2.144%14787.12%8.653.1%
Medical and surgical instruments477.2413.32%1611.90%1716.30%2805.10%43.63%24105.70%310.80%
Cyclic amide compounds438.64.243%316%230.432.1%136.110%0.682%2627.617%0.90.4%
Retail-ready immunology products383.81372.41%2373.10%11024.80%6666.60%129.90%68928.50%193.70%

Total opportunity is the import demand in the FTAs where the product falls under Categories I to III, available if the suggested action is taken. Source: ITC Trade Map.

This advisory is indicative. Duty treatment depends on the exact HS code and the rules of origin in each agreement. Check your product on the Trade Connect portal or contact the Advisory Desk before quoting a buyer.